Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| enteroendocrine cell | 6 studies | 42% ± 19% | |
| pancreatic A cell | 4 studies | 77% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 4 studies | 38% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 294.36 | 328 / 328 | 69% | 49.32 | 122 / 178 |
| prostate | 67% | 33.67 | 163 / 245 | 81% | 3.38 | 406 / 502 |
| adrenal gland | 44% | 50.30 | 114 / 258 | 64% | 65.53 | 147 / 230 |
| stomach | 75% | 64.54 | 270 / 359 | 13% | 0.81 | 36 / 286 |
| brain | 73% | 24.53 | 1931 / 2642 | 10% | 0.25 | 74 / 705 |
| intestine | 52% | 31.60 | 499 / 966 | 25% | 1.92 | 130 / 527 |
| esophagus | 14% | 3.04 | 208 / 1445 | 22% | 0.72 | 40 / 183 |
| uterus | 1% | 0.06 | 1 / 170 | 16% | 0.59 | 74 / 459 |
| lung | 0% | 0.03 | 1 / 578 | 13% | 0.67 | 152 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.33 | 5 / 45 |
| bladder | 0% | 0 | 0 / 21 | 9% | 0.50 | 47 / 504 |
| breast | 2% | 0.37 | 7 / 459 | 7% | 0.71 | 78 / 1118 |
| liver | 1% | 0.20 | 3 / 226 | 5% | 1.23 | 22 / 406 |
| skin | 1% | 0.16 | 10 / 1809 | 5% | 0.15 | 22 / 472 |
| muscle | 4% | 0.87 | 34 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.27 | 2 / 80 |
| adipose | 2% | 0.32 | 20 / 1204 | 0% | 0 | 0 / 0 |
| heart | 2% | 0.42 | 14 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 0.21 | 15 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 1% | 0.15 | 6 / 653 | 0% | 0.00 | 1 / 605 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 5 / 901 |
| spleen | 0% | 0.05 | 1 / 241 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0.00 | 1 / 430 |
| peripheral blood | 0% | 0.02 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002088 | Biological process | lens development in camera-type eye |
| GO_0007601 | Biological process | visual perception |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005212 | Molecular function | structural constituent of eye lens |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | CRYBA2 |
| Protein name | Beta-crystallin A2 (Beta-A2 crystallin) |
| Synonyms | |
| Description | FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. FUNCTION: Crystallins are the dominant structural components of the vertebrate eye lens. . |
| Accessions | P53672 C9JDH2 ENST00000392096.6 ENST00000453769.1 ENST00000295728.7 |